NeuroRecovery Technologies is proud to announce its recent merger with GTX medical who has offices located in Eindhoven, The Netherlands and Lausanne, Switzerland. The combined new entity, GTX medical B.V. is positioned to be a leading global company in neuromodulation therapies to improve functional recovery for individuals living with a spinal cord injury.
LIFT device for Non-invasive Electrical Spinal Stimulation (NESS)
Enabling restoration of motor control and function after a spinal cord injury
After a spinal cord injury communication between the brain and spinal cord is disrupted leading to a block in transmitting signals to and from the brain, to the spinal cord itself, and from the spinal cord to the areas of the body (arms, legs, organ systems) that it helps to regulate and control. All leading to varying degrees of loss of function and paralysis.
Recognizing that there is residual capacity for control of movement and function within the spinal cord following an injury. NESS therapy is applied providing gradual excitation to the spinal cord to enable recovery and restored function; re-establishing communication between spared neural networks and the brain.
What allows this recovery to take place by means of a non-invasive transcutaneous “through the skin” approach is the company’s patented wave forms.
The Medical Breakthrough – How it works
GTX is dedicated to developing disease and injury specific devices to help restore optimal physiology function in individuals suffering with paralysis due to injury and illness. We accomplish this by enabling the reactivation of damaged and dormant neural circuits through neuromodulation of the spinal cord. The method we use is to apply our proprietary stimulator technology below the level of injury targeting neural connections & pathways with our discovered stimulation parameters enabling the spinal cord to re-awaken and recall what it is suppose to do.